Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2026)

Pediatrix Medical (MD) has reported Long-Term Deferred Tax for 9 consecutive years, with $56.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Deferred Tax fell 36.76% year-over-year to $56.1 million in Q2 2026; TTM through Jun 2026 was $56.1 million, a 36.76% decrease from a year earlier, with the FY2025 full-year figure at $73.9 million, down 88.95% from the prior year.
• Long-Term Deferred Tax was $56.1 million for Q2 2026 at Pediatrix Medical, down from $65.7 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $696.6 million in Q4 2022 and troughed at $56.1 million in Q2 2026.
• A 5-year average of $191.3 million and a median of $100.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax soared 65.49% in 2022 and sank 88.95% in 2025, its largest moves.
• Over 5 years, Long-Term Deferred Tax stood at $696.6 million in 2022, then decreased by 1.45% to $686.5 million in 2023, then fell by 2.58% to $668.8 million in 2024, then slumped by 88.95% to $73.9 million in 2025, then fell by 24.09% to $56.1 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $56.1 million (Q2 2026), $65.7 million (Q1 2026), and $73.9 million (Q4 2025), per Business Quant data.